ue to expand GLP-1 NBRx and Novo Nordisk® US GLP-1 TRx market size and market share TRx share 70% 60% 50% 40% Ozempic® NN GLP-1 Rybelsus® Victoza® dulaglutide Class growth around 30% 49.6% 44.3% 30% 20% 10% 0% Jun 2019 26.9% 19.0% 3.7% Oct 2020
Download PDF file